Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000006

Director acquired 1,687 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dubin Glenn Director 2024-01-02 Grant or award +1,687 $6.52 $10,999 20,717 D: show line 1 in the form
Loading xslF345X05/wk-form4_1704316341.xml…